SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001193125-22-039084
Filing Date
2022-02-14
Accepted
2022-02-14 06:11:38
Documents
1
Group Members
ATLAS DIVERSIFIED FUND, L.P.ATLAS DIVERSIFIED FUND, LTDATLAS DIVERSIFIED MASTER FUND, LTD.ATLAS ENHANCED FUND, LPATLAS ENHANCED FUND, LTD.ATLAS ENHANCED MASTER FUND, LTD.ATLAS GLOBAL INVESTMENTS, LTD.ATLAS GLOBAL, LLCATLAS INSTITUTIONAL EQUITY FUND, LPATL

Document Format Files

Seq Description Document Type Size
1 SC 13G/A d293851dsc13ga.htm SC 13G/A 293122
  Complete submission text file 0001193125-22-039084.txt   295092
Mailing Address 444 WEST LAKE STREET 50TH FLOOR CHICAGO IL 60606
Business Address 444 WEST LAKE STREET 50TH FLOOR CHICAGO IL 60606 3124992999
BALYASNY ASSET MANAGEMENT LLC (Filed by) CIK: 0001218710 (see all company filings)

IRS No.: 364472709 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 75 HAYDEN AVENUE LEXINGTON MA 02421
Business Address 75 HAYDEN AVENUE LEXINGTON MA 02421 617 621 8097
Dicerna Pharmaceuticals Inc (Subject) CIK: 0001399529 (see all company filings)

IRS No.: 205993609 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-87866 | Film No.: 22624566
SIC: 2834 Pharmaceutical Preparations